Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.
Journal of the National Cancer Institute|January 25, 2022
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic ImplicationsTony El Jabbour, Maksym Misyura, Darren Cowzer, et al.
JAMA Network Open|August 24, 2022
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal AdenocarcinomaCharlton Tsai, Bastien Nguyen, Anisha Luthra, et al.
Cancer|June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancerKenneth H Yu, Jennifer Park, Avni Mittal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 24, 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinomaMarisa Sewell, Nicolas Toumbacaris, Kay See Tan, et al.
Journal of the National Cancer Institute|January 25, 2022
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic ImplicationsTony El Jabbour, Maksym Misyura, Darren Cowzer, et al.
JAMA Network Open|August 24, 2022
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal AdenocarcinomaCharlton Tsai, Bastien Nguyen, Anisha Luthra, et al.
Cancer|June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancerKenneth H Yu, Jennifer Park, Avni Mittal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Pageof 11